Find a Doctor

Qing M. Xie

Shanghai Jiao Tong University School Of Medicine
Female

Bio


Qing Xie is in Shanghai, China. They have been an author on 483 peer reviewed articles and participated in 2 clinical trials in the past 15 years.

Contact

Shanghai, CN

Latest Advances


Latest Advance
Study
  • Condition: Chronic Hepatitis C Virus (HCV) Infection
  • Journal: The lancet. Gastroenterology & hepatology
  • Treatment Used: Glecaprevir-Pibrentasvir
  • Number of Patients: 362
  • Published —
This study evaluated the safety and effectiveness of glecaprevir-pibrentasvir in the treatment of chronic hepatitis C virus (HCV) infection (infection in the liver caused by the hepatitis C virus).
Latest Advance
Study
  • Condition: Upper Limb Function in Patients with Ischemic Stroke
  • Journal: Journal of neuroengineering and rehabilitation
  • Treatment Used: Cathodal Transcranial Direct Current Stimulation (c-tDCS) with Virtual Reality (VR)
  • Number of Patients: 40
  • Published —
This study investigated whether cathodal transcranial direct current stimulation (c-tDCS) combined with virtual reality (VR) is superior to virtual reality alone in the reduction of motor impairment and improvement of upper limb function and quality of life in patients with ischemic stroke.
Latest Advance
Study
  • Condition: Mild to moderate coronavirus disease 2019
  • Journal: BMJ (Clinical research ed.)
  • Treatment Used: Hydroxychloroquine
  • Number of Patients: 150
  • Published —
The study researched the use of Hydroxychloroquine for patients with mild to moderate coronavirus disease 2019.
Latest Advance
Study
  • Condition: Thyroid Carcinoma
  • Journal: Nigerian journal of clinical practice
  • Treatment Used: Scarless Neck Endoscopic Thyroidectomy via the Breast Approach
  • Number of Patients: 45
  • Published —
This study reported on cases with scarless neck endoscopic total or near-total thyroidectomy plus central compartment dissection (CCD) via the breast approach in the treatment of thyroid cancer.
Latest Advance
Study
  • Condition: Chronic Hepatitis B
  • Journal: The American journal of gastroenterology
  • Treatment Used: Tenofovir Versus Entecavir
  • Number of Patients: 5537
  • Published —
In this study, researchers compared the effectiveness of tenofovir versus entecavir for the prevention of liver cancer in persons with chronic hepatitis C infection.
Latest Advance
Study
  • Condition: Chronic hepatitis B
  • Journal: Medicine
  • Treatment Used: Qingzhong versus Viread
  • Number of Patients: 330
  • Published —
This study analyzed the efficacy and safety of Qingzhong versus Viread in Chinese patients with Chronic hepatitis B.
Latest Advance
Study
  • Condition: Chronic Hepatitis B Virus (HBV) Infection
  • Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Treatment Used: Long-Term Treatment with Entecavir or Other Agents
  • Number of Patients: 6162
  • Published —
This study investigated clinical outcome events and safety associated with long-term treatment with entecavir, followed up patients treated with entecavir or another standard-of-care Hepatitis B Virus (HBV) nucleos(t)ide analogue for up to 10 years, and assessed long-term outcomes and relationships with virologic response.
Latest Advance
Study
  • Condition: Chronic hepatitis B
  • Journal: BMC gastroenterology
  • Treatment Used: Pegylated interferon alfa-2b
  • Number of Patients: 32
  • Published —
This study investigated the effects of peginterferon alfa-2b in patients with chronic hepatitis B.
Latest Advance
Study
  • Condition: Hepatitis C Virus
  • Journal: The lancet. Gastroenterology & hepatology
  • Treatment Used: Sofosbuvir / Velpatasvir
  • Number of Patients: 374
  • Published —
This trial assessed the safety and effectiveness of sofosbuvir and velpatasvir in patients with chronic hepatitis C virus in Asia.
Latest Advance
Study
  • Condition: HBeAg-positive chronic hepatitis B infection
  • Journal: Journal of viral hepatitis
  • Treatment Used: Entecavir and peginterferon add-on therapy
  • Number of Patients: 48
  • Published —
The study researched the safety and effectiveness of entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection.

Contact

Shanghai, CN

Insurance

Contact them to find out if they accept your insurance plan.